Hem

Press release from Companies

Publicerat: 2022-11-15 15:42:56

Redsense Medical AB: Correction: Consolidated cash flow analysis interim report January-September 2022 Redsense Medical AB (publ)

The correction refers to the consolidated cash flow analysis on page 13 of the interim report January-September 2022.

Corrected report is attached and available on redsensemedical.com/investors-media/finansiella-rapporter/

Contact information

For more information, please contact: 
Pontus Nobréus
CEO
Telephone: +46 72-171 1264
E-mail:
pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimizing blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.

Läs mer hos Cision
Läs mer om Redsense Medical AB

Prenumeration